Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-03-01 20:37:31

expired found date

-

created at

2024-06-06 21:50:25

updated at

2025-12-29 22:29:13

Domain name statistics

length

9

crc

16494

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

205300312

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

5

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

2025-11-05 05:19:58

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

35162

mp size raw text

4179

mp inner links count

2

mp inner links status

20 (imported)

Open Graph

title

Syros Pharmaceuticals, Inc. (SYRS)

description

site name

Syros Pharmaceuticals, Inc.

author

updated

2025-12-17 17:25:23

raw text

Syros Pharmaceuticals, Inc. (SYRS) Home Our Coordinated Expression Overview Our Culture, Mission & Values Our Commitment to Diversity, Equity & Inclusion Message from BIO Our People Overview Leadership Board of Directors Programs Overview Tamibarotene SY-2101 SY-5609 Expanded Access Policy Clinical Trials Platform Overview What is Gene Control? Publications and Abstracts Patients Investors & Media Partners Careers Blog Contact Robert MDS Patient An Expression Makes a World of Difference The genes expressed - turned on, off, up or down - in any given cell determine its type and function. When the wrong genes are expressed at the wrong time or in the wrong amounts, it can lead to disease. At Syros, we have identified cancer patients with aberrant expression of genes that can be targeted with new therapies. We are focused on applying this approach to developing new standards of care for the frontline treatment of patients with ...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Nowotwory (78)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

2

text cyrillic

0

text characters

3313

text words

604

text unique words

289

text lines

95

text sentences

25

text paragraphs

8

text words per sentence

24

text matched phrases

6

text matched dictionaries

4

RSS

rss path

rss status

3 (priority 3 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

10 (sitemap found, awaiting processing)

sitemap review version

1

sitemap urls count

320

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-03-04 09:17:48

sitemap process date

-

sitemap first import date

-

sitemap last import date

-